Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank92
3Y CAGR+19.0%
5Y CAGR+11.8%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+19.0%/yr
vs +41.8%/yr prior
5Y CAGR
+11.8%/yr
Recent acceleration
Acceleration
-22.7pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$11.84M-12.8%
2024$13.58M+19.7%
2023$11.34M+61.5%
2022$7.02M+5.3%
2021$6.67M-1.4%
2020$6.77M+10.9%
2019$6.10M+250.8%
2018$1.74M-8.1%
2017$1.89M+12.6%
2016$1.68M-